Seeking Alpha

InSite Vision, Inc. (INSV)

  • Aug. 13, 2014, 4:22 PM
    • InSite Vision (OTCQB:INSV) Q2 results: Revenues: $6.3M (-67.0%); Operating Expenses: $4.1M (-22.3%); Operating Income: $2.3M (-83.9%); Net Income: $37.1M (+206.6%); EPS: $0.28 (+211.1%); Quick Assets: $2.5M (-70.0%).
    • No financial guidance given.
    | Aug. 13, 2014, 4:22 PM | Comment!
Visit Seeking Alpha's
INSV vs. ETF Alternatives
Company Description
InSite Vision is committed to advancing new and superior ophthalmologic products for unmet eye care needs. The Company's lead product is AzaSite*, which targets infections of the eye. AzaSite contains the drug azithromycin, a broad-spectrum antibiotic formulated with DuraSite, InSite Vision's... More